97 related articles for article (PubMed ID: 11599799)
21. Barbigerone inhibits tumor angiogenesis, growth and metastasis in melanoma.
Yang JH; Hu J; Wan L; Chen LJ
Asian Pac J Cancer Prev; 2014; 15(1):167-74. PubMed ID: 24528020
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of endothelial Cdk5 reduces tumor growth by promoting non-productive angiogenesis.
Merk H; Zhang S; Lehr T; Müller C; Ulrich M; Bibb JA; Adams RH; Bracher F; Zahler S; Vollmar AM; Liebl J
Oncotarget; 2016 Feb; 7(5):6088-104. PubMed ID: 26755662
[TBL] [Abstract][Full Text] [Related]
23. Danshensu has anti-tumor activity in B16F10 melanoma by inhibiting angiogenesis and tumor cell invasion.
Zhang LJ; Chen L; Lu Y; Wu JM; Xu B; Sun ZG; Zheng SZ; Wang AY
Eur J Pharmacol; 2010 Sep; 643(2-3):195-201. PubMed ID: 20621088
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine.
Albini A; D'Agostini F; Giunciuglio D; Paglieri I; Balansky R; De Flora S
Int J Cancer; 1995 Mar; 61(1):121-9. PubMed ID: 7705924
[TBL] [Abstract][Full Text] [Related]
25. Preclinical evaluation of the antimetastatic efficacy of Pentoxifylline on A375 human melanoma cell line.
Kamran MZ; Gude RP
Biomed Pharmacother; 2012 Dec; 66(8):617-26. PubMed ID: 23089470
[TBL] [Abstract][Full Text] [Related]
26. Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro.
Hamsa TP; Kuttan G
Eur J Pharmacol; 2010 Dec; 649(1-3):64-73. PubMed ID: 20858484
[TBL] [Abstract][Full Text] [Related]
27. Role of thymosin beta4 in tumor metastasis and angiogenesis.
Cha HJ; Jeong MJ; Kleinman HK
J Natl Cancer Inst; 2003 Nov; 95(22):1674-80. PubMed ID: 14625258
[TBL] [Abstract][Full Text] [Related]
28. 17β-estradiol-linked nitro-L-arginine as simultaneous inducer of apoptosis in melanoma and tumor-angiogenic vascular endothelial cells.
Roy S; Reddy BS; Sudhakar G; Kumar JM; Banerjee R
Mol Pharm; 2011 Apr; 8(2):350-9. PubMed ID: 21291219
[TBL] [Abstract][Full Text] [Related]
29. Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growth.
Paschoalin T; Carmona AK; Rodrigues EG; Oliveira V; Monteiro HP; Juliano MA; Juliano L; Travassos LR
Mol Cancer; 2007 Jul; 6():44. PubMed ID: 17620116
[TBL] [Abstract][Full Text] [Related]
30. Effects of pentoxifylline on the different steps during adhesion and transendothelial migration of flowing neutrophils.
Bahra PS; Rainger GE; Wautier JL; Nash GB
Cell Biochem Funct; 2001 Dec; 19(4):249-57. PubMed ID: 11746205
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow-derived cells are recruited by the melanoma tumor with endothelial cells contributing to tumor vasculature.
Bonfim-Silva R; Souza LE; Melo FU; Oliveira VC; Magalhães DA; Oliveira HF; Covas DT; Fontes AM
Clin Transl Oncol; 2017 Jan; 19(1):125-133. PubMed ID: 27188167
[TBL] [Abstract][Full Text] [Related]
32. Establishment of a quantitative mouse dorsal air sac model and its application to evaluate a new angiogenesis inhibitor.
Funahashi Y; Wakabayashi T; Semba T; Sonoda J; Kitoh K; Yoshimatsu K
Oncol Res; 1999; 11(7):319-29. PubMed ID: 10757446
[TBL] [Abstract][Full Text] [Related]
33. Antiangiogenic activity of ursolic acid.
Kanjoormana M; Kuttan G
Integr Cancer Ther; 2010 Jun; 9(2):224-35. PubMed ID: 20462855
[TBL] [Abstract][Full Text] [Related]
34. Pentoxifylline attenuation of experimental hepatopulmonary syndrome.
Zhang J; Ling Y; Tang L; Luo B; Chacko BK; Patel RP; Fallon MB
J Appl Physiol (1985); 2007 Mar; 102(3):949-55. PubMed ID: 17110505
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of inflammatory corneal angiogenesis by TNP-470.
Joussen AM; Beecken WD; Moromizato Y; Schwartz A; Kirchhof B; Poulaki V
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2510-6. PubMed ID: 11581191
[TBL] [Abstract][Full Text] [Related]
36. Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis.
Nie D; Lamberti M; Zacharek A; Li L; Szekeres K; Tang K; Chen Y; Honn KV
Biochem Biophys Res Commun; 2000 Jan; 267(1):245-51. PubMed ID: 10623605
[TBL] [Abstract][Full Text] [Related]
37. Expression of adenosine receptors and vegf during angiogenesis and its inhibition by pentoxifylline-A study using zebrafish model.
Nathan JR; Lakshmanan G; Michael FM; Seppan P; Ragunathan M
Biomed Pharmacother; 2016 Dec; 84():1406-1418. PubMed ID: 27802896
[TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM
Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447
[TBL] [Abstract][Full Text] [Related]
39. Mycophenolate mofetil inhibits tumor growth and angiogenesis in vitro but has variable antitumor effects in vivo, possibly related to bioavailability.
Koehl GE; Wagner F; Stoeltzing O; Lang SA; Steinbauer M; Schlitt HJ; Geissler EK
Transplantation; 2007 Mar; 83(5):607-14. PubMed ID: 17353782
[TBL] [Abstract][Full Text] [Related]
40. The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth.
Ruggeri BA; Robinson C; Angeles T; Wilkinson J; Clapper ML
Clin Cancer Res; 2002 Jan; 8(1):267-74. PubMed ID: 11801568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
